| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...869495R |
| P356 | DOI | 10.1371/JOURNAL.PONE.0069495 |
| P8608 | Fatcat ID | release_u65muoe7gfclpkdq2lcxpbdvcy |
| P932 | PMC publication ID | 3718736 |
| P698 | PubMed publication ID | 23894495 |
| P5875 | ResearchGate publication ID | 253336493 |
| P50 | author | Gabrielle Richard | Q115599715 |
| P2093 | author name string | Mehdi Arbabi-Ghahroudi | |
| Roger MacKenzie | |||
| J Christopher Hall | |||
| Ashley J Meyers | |||
| Michael D McLean | |||
| P2860 | cites work | Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH | Q57838453 |
| A bispecific nanobody to provide full protection against lethal scorpion envenoming | Q57985793 | ||
| Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom | Q57985805 | ||
| Comparison of llama VH sequences from conventional and heavy chain antibodies | Q57985853 | ||
| Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features | Q63804727 | ||
| Isolation of the principal neurotoxins of Naja naja subspecies from the Asian mainland | Q70478985 | ||
| Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol | Q74292060 | ||
| Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins | Q75390422 | ||
| Confronting the neglected problem of snake bite envenoming: the need for a global partnership | Q21563433 | ||
| Snake-bites: appraisal of the global situation | Q24651991 | ||
| Structural Basis of Neutralization of the Major Toxic Component from the Scorpion Centruroides noxius Hoffmann by a Human-derived Single-chain Antibody Fragment | Q27667506 | ||
| Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme | Q27733338 | ||
| Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage | Q28138228 | ||
| Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies | Q28141943 | ||
| Selection and identification of single domain antibody fragments from camel heavy-chain antibodies | Q28250517 | ||
| Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia) | Q28251242 | ||
| Naturally occurring antibodies devoid of light chains | Q28269589 | ||
| Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain | Q28302768 | ||
| Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants | Q30320231 | ||
| Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. | Q30356869 | ||
| Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium | Q30790381 | ||
| Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama | Q30879327 | ||
| Efficient cancer therapy with a nanobody-based conjugate | Q33201668 | ||
| Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development | Q33270553 | ||
| Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol | Q33352416 | ||
| Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin | Q33402028 | ||
| Selection of non-aggregating VH binders from synthetic VH phage-display libraries | Q33413807 | ||
| Selection of single chain variable fragment (scFv) antibodies from a hyperimmunized phage display library for the detection of the antibiotic monensin | Q33624616 | ||
| Selection and expression of recombinant single domain antibodies from a hyper-immunized library against the hapten azoxystrobin | Q33967534 | ||
| Trends in snakebite envenomation therapy: scientific, technological and public health considerations | Q34008009 | ||
| Expression of single-domain antibodies in bacterial systems | Q34377121 | ||
| Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment | Q34675779 | ||
| Snake antivenoms | Q35154674 | ||
| Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation | Q35170845 | ||
| A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro | Q36094806 | ||
| Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library | Q36872918 | ||
| Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology. | Q38952254 | ||
| Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa | Q38952257 | ||
| Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera | Q39051054 | ||
| Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells | Q39662620 | ||
| Complexes with anti-epitope tag IgGs improve the therapeutic potential of epitope-tagged antibody fragments | Q39739910 | ||
| VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'. | Q40072713 | ||
| Efficient tumor targeting by single-domain antibody fragments of camels | Q40650068 | ||
| Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom | Q40837917 | ||
| Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites | Q41143826 | ||
| Potent enzyme inhibitors derived from dromedary heavy-chain antibodies | Q41782789 | ||
| Preparation, characterization and immunogenicity of various polymers and conjugates of elapid postsynaptic neurotoxins | Q42101978 | ||
| Neutralization of Bothrops mattogrossensis snake venom from Bolivia: experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation | Q43300756 | ||
| Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs | Q46719871 | ||
| Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies | Q47346670 | ||
| Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants | Q47861912 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | e69495 | |
| P577 | publication date | 2013-07-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody | |
| P478 | volume | 8 |
| Q36134100 | A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies |
| Q35173029 | A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model |
| Q39201557 | Alpha-type phospholipase A2 inhibitors from snake blood. |
| Q26740788 | An update on antibody-based immunotherapies for Clostridium difficile infection |
| Q33612077 | Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming. |
| Q55504537 | Basics of Antibody Phage Display Technology. |
| Q26741744 | Biotechnological Trends in Spider and Scorpion Antivenom Development |
| Q55179438 | Camelid Single-Domain Antibodies (VHHs) against Crotoxin: A Basis for Developing Modular Building Blocks for the Enhancement of Treatment or Diagnosis of Crotalic Envenoming. |
| Q39002539 | Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases. |
| Q49160630 | Comparison of VHH-Fc antibody production in Arabidopsis thaliana, Nicotiana benthamiana and Pichia pastoris. |
| Q27304633 | Description of a nanobody-based competitive immunoassay to detect tsetse fly exposure |
| Q35754076 | Distribution of immunoglobulin G antibody secretory cells in small intestine of Bactrian camels (Camelus bactrianus) |
| Q47312316 | Expression of single-domain antibody in different systems |
| Q92239571 | History of Envenoming Therapy and Current Perspectives |
| Q35699428 | Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain. |
| Q35974249 | Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments. |
| Q58646940 | Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms |
| Q47121798 | Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy |
| Q97531501 | Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 |
| Q28543136 | Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome |
| Q56889475 | Recent Advances in Next Generation Snakebite Antivenoms |
| Q97644587 | Recombinant antibodies against Iranian cobra venom as a new emerging therapy by phage display technology |
| Q26795434 | Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs |
| Q46343507 | Snakebite envenoming |
| Q42291081 | Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy |
| Q92454115 | The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins |
| Q61814870 | Toxin Neutralization Using Alternative Binding Proteins |
| Q58647020 | Toxin synergism in snake venoms |
| Q92455760 | mRNA: A Novel Avenue to Antibody Therapy? |
Search more.